Torrent Pharmaceuticals Ltd

Torrent Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Torrent Pharmaceuticals Ltd

₹ 3,752 -0.04%
27 Nov 9:19 a.m.
torrentpharma.com BSE: 500420 NSE: TORNTPHARM
About

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.[1]

It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses.[2]

Key Points

Product Segments Q2 FY25
1) Branded Generics (74%): [1] The company’s branded generics business focuses on the manufacturing pharmaceutical products under its brand names catering to various therapeutic segments including cardiovascular, central nervous system, gastrointestinal, vitamin mineral nutrients, dermatology, diabetes, pain management and gynecology. Its branded generic medicines are marketed in key regions including India and Brazil. [2]

Website BSE NSE
  • Market Cap ₹ 1,26,984 Cr.
  • Current Price ₹ 3,752
  • High / Low ₹ 3,882 / 2,886
  • Stock P/E 58.6
  • Book Value ₹ 250
  • Dividend Yield 0.85 %
  • ROCE 27.0 %
  • ROE 26.5 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company has been maintaining a healthy dividend payout of 57.9%

Cons

  • Stock is trading at 15.0 times its book value
  • The company has delivered a poor sales growth of 7.72% over past five years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare BSE 200 BSE Dollex 200 Nifty Next 50

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
2,291 2,491 2,491 2,591 2,660 2,732 2,745 2,859 2,889 2,809 2,959 3,178 3,302
1,612 1,767 1,764 1,800 1,835 1,863 1,862 1,955 1,950 1,895 1,995 2,146 2,219
Operating Profit 679 724 727 791 825 869 883 904 939 914 964 1,032 1,083
OPM % 30% 29% 29% 31% 31% 32% 32% 32% 32% 33% 33% 32% 33%
16 -10 9 34 26 55 31 24 -16 33 -42 -37 -40
Interest 69 102 107 103 91 80 80 75 64 57 56 56 48
Depreciation 163 193 196 191 201 213 203 197 198 199 201 201 204
Profit before tax 463 419 433 531 559 631 631 656 661 691 665 738 791
Tax % 33% 30% 34% 29% 31% 30% 29% 30% 31% 27% 25% 26% 25%
312 292 287 378 386 443 449 457 453 503 498 548 591
EPS in Rs 9.22 8.63 8.48 11.17 11.41 13.09 13.27 13.50 13.39 14.86 14.71 16.19 17.46
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
4,172 4,636 6,687 5,816 5,950 7,673 7,939 8,005 8,508 9,620 10,728 11,516 12,248
3,216 3,616 3,954 4,438 4,601 5,690 5,769 5,524 6,077 6,778 7,360 7,795 8,255
Operating Profit 955 1,020 2,733 1,377 1,349 1,983 2,170 2,480 2,431 2,842 3,368 3,721 3,993
OPM % 23% 22% 41% 24% 23% 26% 27% 31% 29% 30% 31% 32% 33%
34 286 32 223 299 -300 121 57 -288 45 146 -1 -86
Interest 59 175 184 206 308 504 451 353 255 333 354 252 217
Depreciation 87 191 238 307 409 618 654 658 662 707 808 795 805
Profit before tax 844 940 2,343 1,088 931 562 1,187 1,526 1,226 1,847 2,352 2,673 2,885
Tax % 21% 20% 26% 14% 27% 22% 14% 18% 37% 33% 30% 28%
664 751 1,733 934 678 436 1,025 1,252 777 1,245 1,656 1,911 2,140
EPS in Rs 19.62 22.19 51.22 27.59 20.04 12.89 30.28 36.99 22.97 36.79 48.94 56.47 63.22
Dividend Payout % 25% 25% 34% 25% 35% 66% 53% 47% 105% 60% 57% 57%
Compounded Sales Growth
10 Years: 10%
5 Years: 8%
3 Years: 11%
TTM: 9%
Compounded Profit Growth
10 Years: 10%
5 Years: 14%
3 Years: 21%
TTM: 25%
Stock Price CAGR
10 Years: 18%
5 Years: 23%
3 Years: 32%
1 Year: 16%
Return on Equity
10 Years: 23%
5 Years: 23%
3 Years: 24%
Last Year: 27%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 85 85 85 85 85 85 85 85 85 169 169 169 169
Reserves 1,818 2,406 3,409 4,266 4,538 4,640 4,739 5,753 5,868 6,029 6,687 7,421 8,280
1,132 2,740 2,352 2,510 6,462 6,038 5,784 4,874 4,070 5,369 4,022 3,202 2,822
1,988 2,589 3,040 2,740 3,159 3,351 3,402 3,363 2,884 3,043 3,627 3,603 4,244
Total Liabilities 5,022 7,820 8,886 9,601 14,243 14,113 14,010 14,075 12,906 14,610 14,505 14,396 15,515
875 2,833 2,859 3,688 7,855 7,748 7,533 7,065 6,423 8,121 8,138 7,947 7,841
CWIP 534 678 1,042 519 647 617 712 889 630 765 361 478 488
Investments 186 298 780 804 492 353 2 181 226 199 173 156 133
3,427 4,011 4,206 4,589 5,249 5,395 5,763 5,940 5,628 5,524 5,834 5,815 7,053
Total Assets 5,022 7,820 8,886 9,601 14,243 14,113 14,010 14,075 12,906 14,610 14,505 14,396 15,515

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
599 810 2,742 1,009 894 1,798 1,393 2,005 1,803 2,368 3,266 2,585
-418 -2,113 -869 -798 -4,677 -246 229 -444 -196 -2,335 -160 -549
86 1,212 -1,435 -193 3,417 -1,314 -1,549 -1,651 -1,781 77 -2,780 -2,298
Net Cash Flow 268 -90 437 18 -366 238 73 -89 -174 110 327 -262

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 96 125 79 60 77 68 76 69 70 74 63 59
Inventory Days 297 275 314 318 429 318 362 456 368 298 310 334
Days Payable 421 472 523 356 447 345 345 351 250 224 284 239
Cash Conversion Cycle -28 -71 -130 21 59 42 93 174 188 147 89 154
Working Capital Days 24 29 -1 28 -80 -62 -52 -5 7 -33 -27 7
ROCE % 35% 27% 48% 19% 13% 13% 15% 17% 19% 20% 23% 27%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 68.31% 68.31% 68.31% 68.31%
12.09% 12.04% 12.85% 13.15% 14.08% 14.14% 14.22% 14.46% 16.17% 16.31% 16.09% 15.92%
8.77% 8.89% 8.22% 7.91% 7.11% 7.15% 7.17% 6.98% 8.25% 8.25% 8.54% 9.17%
0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10%
7.78% 7.71% 7.59% 7.59% 7.46% 7.34% 7.25% 7.21% 7.17% 7.02% 6.93% 6.47%
No. of Shareholders 65,23763,83161,57269,61269,11771,15474,76579,84885,03586,00581,85678,226

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls